Status:
WITHDRAWN
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Benign Prostatic Hyperplasia
Prostate Cancer
Eligibility:
MALE
20+ years
Brief Summary
Benign prostatic hyperplasia(BPH) is a common disease in urology among old men. If BPH symptom cannot be controlled by drugs, then transurethral resection of the prostate (TURP), is recommended. Altho...
Eligibility Criteria
Inclusion
- Admitted to National Cheng Kung University Hospital Urology during the study
- Older than 20 years old
- Agree to participate this study
- Receiving transurethral resection of the prostate for benign prostatic hyperplasia or prostate cancer
Exclusion
- Poor expression ability and without close care givers to answer questions
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02822963
Start Date
March 1 2016
End Date
August 1 2016
Last Update
October 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan